Nature's Sunshine Products NATR Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Asia | $221.78M+6.7% | $207.79M+3.3% | $201.25M+8.0% | $186.29M+5.3% | |
| Europe | $93.13M+9.8% | $84.84M+4.6% | $81.1M+2.7% | $78.99M-13.7% | |
| Latin America and Other | $21.62M-5.5% | $22.88M-1.2% | $23.16M-1.1% | $23.41M-9.7% | |
| North America | $143.61M+3.4% | $138.85M-0.7% | $139.8M+4.9% | $133.21M-11.0% | |
| Net Sales by Product | |||||
| Cardiovascular | $81.64M-0.1% | $81.7M-2.3% | $83.59M+3.5% | $80.74M+3.5% | |
| Digestive | $124.37M+11.3% | $111.74M+7.6% | $103.87M+8.2% | $96.01M-10.0% | |
| General health | $192.12M+4.5% | $183.88M+5.8% | $173.77M+9.1% | $159.26M-2.3% | |
| Immunity | $40.82M+5.4% | $38.72M+19.3% | $32.47M+9.5% | $29.64M-9.6% | |
| Personal care | $23.27M+30.7% | $17.8M-2.7% | $18.3M-15.5% | $21.67M-34.5% | |
| Weight management | $17.93M-12.6% | $20.51M-38.4% | $33.32M-3.7% | $34.6M+13.2% | |
| Net Sales by Geography | |||||
| Japan | $56.07M+27.6% | $43.94M— | —— | —— | |
| South Korea | $50.84M-1.0% | $51.36M-2.7% | $52.78M-3.9% | $54.94M-10.1% | |
| Taiwan | $67.28M-4.7% | $70.58M+20.1% | $58.76M+21.2% | $48.47M+109% | |
| United States | $133.39M+4.3% | $127.92M-1.1% | $129.31M+5.2% | $122.86M-11.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Nature's Sunshine Products break its business down?
- Nature's Sunshine Products (NATR) reports net sales by business across 4 parts — Asia, Europe, Latin America and Other and North America. Each is extracted from the segment footnotes and tracked over time.
- Where does Nature's Sunshine Products's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Nature's Sunshine Products's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
